Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Palmer

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The British Journal of Surgery|March 24, 2012
Epidemiological burden of minor, major and fatal trauma in a national injury pyramid (Br J Surg 2012; 99(Suppl 1): 114-121)C S Palmer
Veterinary Medicine, Small Animal Clinician : VM, SAC|October 1, 1970
Osteochondritis dissecans in great danesC S Palmer
Archives of Internal Medicine|March 28, 1994
Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohortS A Grover, C S Palmer, L Coupal
The Journal of the American Board of Family Practice|March 2, 1999
Treatment patterns for otitis externaM T Halpern, C S Palmer, M Seidlin
The British Journal of Surgery|October 13, 2017
Revised Functional Capacity Index as a predictor of outcome following injuryC S Palmer, B J Gabbe, P A Cameron
Acta Radiologica (Stockholm, Sweden : 1987)|July 9, 2008
Fat-suppressed T2* sequences for routine 3.0-tesla lumbar spine magnetic resonance imaging: a preliminary reportA M McKinney, S Gadani, C S Palmer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 12, 2001
Patient preferences and utilities for 'off-time' outcomes in the treatment of Parkinson's diseaseC S Palmer, J K Schmier, E Snyder, et al.
Journal of Public Health Management and Practice : JPHMP|April 7, 1998
A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosisC S Palmer, B Miller, M T Halpern, et al.
The American Journal of Managed Care|May 7, 1998
A pharmacoeconomic analysis of rimexolone for the treatment of ophthalmic inflammatory conditionsM T Halpern, C S Palmer, S Foster, et al.
Canadian Medical Association Journal|May 1, 1985
Patterns of preventive practice in New BrunswickR N Battista, C S Palmer, B M Marchand, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The British Journal of Surgery|March 24, 2012
Epidemiological burden of minor, major and fatal trauma in a national injury pyramid (Br J Surg 2012; 99(Suppl 1): 114-121)C S Palmer
Veterinary Medicine, Small Animal Clinician : VM, SAC|October 1, 1970
Osteochondritis dissecans in great danesC S Palmer
Archives of Internal Medicine|March 28, 1994
Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohortS A Grover, C S Palmer, L Coupal
The Journal of the American Board of Family Practice|March 2, 1999
Treatment patterns for otitis externaM T Halpern, C S Palmer, M Seidlin
The British Journal of Surgery|October 13, 2017
Revised Functional Capacity Index as a predictor of outcome following injuryC S Palmer, B J Gabbe, P A Cameron
Acta Radiologica (Stockholm, Sweden : 1987)|July 9, 2008
Fat-suppressed T2* sequences for routine 3.0-tesla lumbar spine magnetic resonance imaging: a preliminary reportA M McKinney, S Gadani, C S Palmer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 12, 2001
Patient preferences and utilities for 'off-time' outcomes in the treatment of Parkinson's diseaseC S Palmer, J K Schmier, E Snyder, et al.
Journal of Public Health Management and Practice : JPHMP|April 7, 1998
A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosisC S Palmer, B Miller, M T Halpern, et al.
The American Journal of Managed Care|May 7, 1998
A pharmacoeconomic analysis of rimexolone for the treatment of ophthalmic inflammatory conditionsM T Halpern, C S Palmer, S Foster, et al.
Canadian Medical Association Journal|May 1, 1985
Patterns of preventive practice in New BrunswickR N Battista, C S Palmer, B M Marchand, et al.
Pageof 3